Trexquant Investment’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.46M | Buy |
+106,281
| New | +$3.46M | 0.04% | 672 |
|
|
2025
Q1 | – | Sell |
-66,249
| Closed | -$5.42M | – | 1787 |
|
|
2024
Q4 | $5.42M | Sell |
66,249
-13,689
| -17% | -$1.12M | 0.06% | 499 |
|
|
2024
Q3 | $9.13M | Buy |
+79,938
| New | +$9.13M | 0.12% | 265 |
|
|
2023
Q4 | – | Sell |
-43,329
| Closed | -$2.21M | – | 1699 |
|
|
2023
Q3 | $2.21M | Buy |
43,329
+38,058
| +722% | +$1.94M | 0.06% | 461 |
|
|
2023
Q2 | $263K | Sell |
5,271
-33,893
| -87% | -$1.69M | 0.01% | 1235 |
|
|
2023
Q1 | $1.47M | Buy |
39,164
+22,559
| +136% | +$846K | 0.04% | 573 |
|
|
2022
Q4 | $796K | Buy |
+16,605
| New | +$796K | 0.02% | 735 |
|
|
2022
Q3 | – | Sell |
-16,851
| Closed | -$367K | – | 1735 |
|
|
2022
Q2 | $367K | Buy |
+16,851
| New | +$367K | 0.02% | 1013 |
|